Mytesi

Call
Website
201 Mission St Ste 2375
San Francisco, CA 94105
+1 (415) 963-9938
https://mytesi.com

Mytesi is an antidiarrheal medication specifically indicated for the symptomatic relief of noninfectious diarrhea in adult patients living with HIV/AIDS who are on antiretroviral therapy. The drug aims to improve the quality of life for those affected, with studies showing that a significant majority of users experience fewer watery stools after treatment.

Developed by Napo Pharmaceuticals, Mytesi is derived from natural sources and is part of a broader commitment to sustainability, supporting local and Indigenous communities through reforestation initiatives. The company emphasizes the importance of patient education and empowerment, providing resources to help individuals discuss their symptoms with healthcare providers.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs and drug proprietaries

Curae Pharma360 Inc

Curae Pharma360 Inc. is a mission-driven pharmaceutical company based in San Francisco, CA, dedicated to ensuring equitable and affordable access to medicines for all individuals. As a for-profit subsidiary of Medicines360, a nonprofit pharmaceutical organization, Curae Pharma360 Inc. is committed to protecting the privacy and security of personal information while striving to advance their mission.Generated from the website
Physical fitness clubs with training equipment

Medicines360

Medicines360 is a health innovation organization based in San Francisco dedicated to breaking barriers to healthcare access for women, particularly the underserved. With a focus on transforming promising ideas into life-changing health products, the organization strives to improve the lives of women through innovative approaches and strategic partnerships. At the core of Medicines360's mission is a commitment to equitable access to optimal health for women globally. By leveraging diverse funding sources and extensive expertise, they aim to accelerate the development and commercialization of high-quality, affordable healthcare solutions tailored to women's needs. Generated from the website

Accengen Therapeutics Inc

AccenGen Therapeutics, Inc. is an early-stage pharmaceutical company based in San Francisco, CA, dedicated to the research and development of novel, first-in-class medications for human health. With a focus on soluble epoxide hydrolase (sEH) inhibitors and dual sEH COX inhibitors, the company aims to address indications with fibrotic etiologies and the highest unmet needs, prioritizing the treatment of pulmonary fibrosis, a disease considered more severe than many cancers. Utilizing their sEH core technology platform, AccenGen Therapeutics offers a range of product opportunities and diversified risk, supported by a wealth of scientific research with over 800 publications in top-tier peer-reviewed journals. Committed to making a significant impact on human health, the company's innovative approach holds promise for improving the lives of individuals affected by debilitating fibrotic conditions.Generated from the website
United States›California›San Francisco›Mytesi

Partial Data by Infogroup (c) 2025. All rights reserved.